Compare MMA & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | MMA | HIND |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | Australia | United States |
| Employees | N/A | 18 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8M | 13.8M |
| IPO Year | 2023 | 2016 |
| Metric | MMA | HIND |
|---|---|---|
| Price | $0.57 | $2.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | ★ 209.1K | 24.6K |
| Earning Date | 05-20-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.35 | $1.75 |
| 52 Week High | $2.00 | $12.87 |
| Indicator | MMA | HIND |
|---|---|---|
| Relative Strength Index (RSI) | 50.49 | 49.53 |
| Support Level | $0.35 | $2.02 |
| Resistance Level | $0.58 | $2.41 |
| Average True Range (ATR) | 0.05 | 0.17 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 79.66 | 55.07 |
MMA Inc develops technology solutions for the martial arts and combat sports sector. Its platform is designed to support gyms and related businesses by improving areas such as sales channels, customer onboarding, and member engagement. The platform also connects participants, gyms, and communities within the sector, enabling digital management and interaction.
Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.